111 related articles for article (PubMed ID: 12694355)
1. Salivary gland tumours: immunoexpression of integrins beta 1, beta 3 and beta 4.
Loducca SV; Mantesso A; Kapas S; Williams DM; Araújo NS; Araújo VC
J Oral Pathol Med; 2003 May; 32(5):305-9. PubMed ID: 12694355
[TBL] [Abstract][Full Text] [Related]
2. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
3. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression.
Araújo VC; Loducca SV; Sousa SO; Williams DM; Araújo NS
Ann Diagn Pathol; 2001 Dec; 5(6):330-4. PubMed ID: 11745070
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 8 expression in salivary gland tumors.
Darling MR; Tsai S; Jackson-Boeters L; Daley TD; Diamandis EP
Head Neck Pathol; 2008 Sep; 2(3):169-74. PubMed ID: 20614312
[TBL] [Abstract][Full Text] [Related]
5. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: distinct architectural composition revealed by collagen IV, laminin and their integrin ligands (alpha2beta1 and alpha3beta1).
Loducca SV; Raitz R; Araújo NS; Araújo VC
Histopathology; 2000 Aug; 37(2):118-23. PubMed ID: 10931234
[TBL] [Abstract][Full Text] [Related]
6. Fine needle aspiration cytology of salivary gland lesions.
Jayaram G; Verma AK; Sood N; Khurana N
J Oral Pathol Med; 1994 Jul; 23(6):256-61. PubMed ID: 7932245
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of galectin-3, beta-catenin, and cyclin D1 in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Neto MM; dos Santos E; dos Santos Pinto D; de Sousa SO
J Oral Pathol Med; 2009 Oct; 38(9):701-7. PubMed ID: 19659475
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of salivary gland swelling: an institutional experience.
Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M
BMC Res Notes; 2015 Mar; 8():101. PubMed ID: 25879702
[TBL] [Abstract][Full Text] [Related]
11. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
12. Detection of C-KIT (CD117) molecule in benign and malignant salivary gland tumours.
Andreadis D; Epivatianos A; Poulopoulos A; Nomikos A; Papazoglou G; Antoniades D; Barbatis C
Oral Oncol; 2006 Jan; 42(1):57-65. PubMed ID: 16140564
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 immunoprofile in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of salivary glands.
Ferrazzo KL; Alves SM; Santos E; Martins MT; de Sousa SM
Oral Oncol; 2007 Jul; 43(6):580-5. PubMed ID: 16996782
[TBL] [Abstract][Full Text] [Related]
14. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
15. C-kit expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):586-93. PubMed ID: 12738950
[TBL] [Abstract][Full Text] [Related]
16. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of galectin-1 and galectin-3 in benign and malignant salivary gland neoplasms.
Xu XC; Sola Gallego JJ; Lotan R; El-Naggar AK
Int J Oncol; 2000 Aug; 17(2):271-6. PubMed ID: 10891535
[TBL] [Abstract][Full Text] [Related]
18. Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.
Westernoff TH; Jordan RC; Regezi JA; Ramos DM; Schmidt BL
Oral Oncol; 2005 Feb; 41(2):170-4. PubMed ID: 15695119
[TBL] [Abstract][Full Text] [Related]
19. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A
Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188
[TBL] [Abstract][Full Text] [Related]
20. Correlation of human Bub1 expression with tumor-proliferating activity in salivary gland tumors.
Shigeishi H; Yoneda S; Taki M; Nobumori T; Ohta K; Higashikawa K; Yasui W; Kamata N
Oncol Rep; 2006 Apr; 15(4):933-8. PubMed ID: 16525682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
